HIMALAYA THERAPEUTICS
Himalaya Therapeutics specializes in making CAB antibodies for cancer patients that reduce tumor toxicity.
HIMALAYA THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Health Care
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.himalayatherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Current Advisors List
Current Employees Featured
Founder
Key Employee Changes
| Date | New article |
|---|---|
| 2021-04-26 | Himalaya Therapeutics Announces Appointment of Brian Zhang as Chief Executive Officer |
Official Site Inspections
http://www.himalayatherapeutics.com Semrush global rank: 6.07 M Semrush visits lastest month: 1.34 K
Unable to get host informations!!!
More informations about "Himalaya Therapeutics"
Himalaya Therapeutics – Bettering Lives
The need for high safer and more potent therapies for cancer patients led Himalaya to the Conditionally Active Biologics (CAB) technology. CAB antibodies are innovative, differentiated therapeutics.See details»
Himalaya Therapeutics - Crunchbase Company Profile & Funding
Himalaya Therapeutics specializes in making CAB antibodies for cancer patients that reduce tumor toxicity.See details»
Meet Himalaya – Himalaya Therapeutics
Our experienced teams support development and commercialization of our products from discovery to market independently as well as with strategic partners.See details»
Himalaya Therapeutics - PitchBook
Www.himalayatherapeutics.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 90 North Church Street; Strathvale House; George …See details»
Himalaya Therapeutics - VentureRadar
"Himalaya is a clinical stage, therapeutic company focused on developing innovative, differentiated therapies in greater china and worldwide. The company has exclusive rights to …See details»
Himalaya Therapeutics - LinkedIn
Himalaya Therapeutics | 252 followers on LinkedIn. Clinical stage, therapeutic company focused on developing innovative, differentiated cancer therapies in Greater ChinaSee details»
Himalaya Therapeutics - Overview, News & Similar companies
Aug 23, 2021 Who is Himalaya Therapeutics. Himalaya is a global clinical-stage biotechnology company that is advancing its deep pipeline of novel monoclonal antibody and other protein …See details»
HIMALAYA THERAPEUTICS ANNOUNCES APPOINTMENT OF …
SAN DIEGO, April 26, 2021 /PRNewswire/ – Himalaya Therapeutics (“Himalaya”), a clinical-stage biopharmaceutical company focused on development and commercialization in Greater China …See details»
Himalaya Therapeutics Announces Registration of its Office in …
Aug 23, 2021 SHANGHAI and SAN DIEGO, Aug. 23, 2021 /PRNewswire/ -- Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on …See details»
BIOATLA SUBSIDIARY, HIMALAYA THERAPEUTICS, WILL DEVELOP …
Apr 16, 2019 First Conditionally Active Biologics licensing participation in Greater China territory San Diego, CA - April 16, 2019 - BioAtla ©, LLC, a global clinical-stage biotechnology …See details»
Himalaya Therapeutics Announces Registration of its Office in …
Aug 23, 2021 SHANGHAI and SAN DIEGO, Aug. 23, 2021 /PRNewswire/ -- Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on …See details»
Himalaya Therapeutics Highlights Recent Clinical Progress
Nov 8, 2022 (San Diego and Shanghai, November 8, 2022) Himalaya Therapeutics (“Himalaya”), a clinical-stage biopharmaceutical company focused on development and commercialization of …See details»
HIMALAYA THERAPEUTICS ANNOUNCES APPOINTMENT OF …
May 3, 2021 Dr. Li has a track record of successfully moving product candidates through clinical development in the U.S. and China. He is currently the CEO and founder of DeltaMed, a …See details»
Himalaya Therapeutics Announces Appointment of Nicholas
Apr 19, 2021 "Nick brings Himalaya a unique mix of both U.S. and China experience in finance, operations and biotechnology that we think will be a critical addition to the Himalaya team," …See details»
BioAtla Subsidiary, Himalaya Therapeutics, Will Develop And ...
SAN DIEGO, April 16, 2019 /PRNewswire/ -- BioAtla ®, LLC, a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) protein …See details»
Himalaya Therapeutics Announces Highlights of Recent ... - BioSpace
Nov 8, 2022 On November 3, Himalaya's collaboration partner, BioAtla, Inc. (NASDAQ: BCAB) publicly announced operational updates described below on the ongoing global clinical trials …See details»
HIMALAYA THERAPEUTICS ANNOUNCES REGISTRATION OF ITS …
Aug 23, 2021 SHANGHAI and SAN DIEGO, Aug. 23, 2021 /PRNewswire/ – Himalaya Therapeutics (“Himalaya”), a clinical-stage biopharmaceutical company focused on …See details»
Himalaya Therapeutics Announces Appointment of Howe Li as
May 3, 2021 Dr. Li has a track record of successfully moving product candidates through clinical development in the U.S. and China. He is currently the CEO and founder of DeltaMed, a …See details»
Himalaya Therapeutics Announces Highlights of Recent Clinical …
Nov 8, 2022 Mecbotamab vedotin (BA3011) Phase 2 part 1 interim results in NSCLC continue to show antitumor activity with additional patients enrolled; HTBA3011 Undifferentiated …See details»
Technology And Pipeline – Himalaya Therapeutics
By using this platform, we have a deep pipeline of product candidates that target a range of validated proteins expressed on tumor cells. The broad applicability of the CAB technology …See details»